Critical Advances in Bronchiectasis Treatment and the Foundational Role of
Neutrophil-Mediated Inflammation in NCFBE
Reducing Exacerbations, Improving FEV1, and Optimizing Quality of Life with Brensocatib at the Front Lines of Bronchiectasis Care—A Year 2026 Clinical Success Update for NCFBE
LEARN MORE > 
Biomarker-Directed Stratification, Evolving
Therapies and Clinical Trials for
Relapsed/Refractory Nodal Therapies and Clinical Trials for
TFH Cell Lymphoma
The Current and Evolving Role and
Guidelines for the Dual Delta-Gamma
PI3K Inhibitor Duvelisib
LEARN MORE > Guidelines for the Dual Delta-Gamma
PI3K Inhibitor Duvelisib
The Role, Pathoimmunobiology, and Translational Implications of a
Novel, Engineered Cytokine Fusion Protein Targeting the Interleukin-2 (IL-2) Pathway
Focusing on Nemvaleukin in Mucosal Melanoma and Ovarian Cancer
LEARN MORE > 
Focus On Targeted CRF1 Receptor Antagonism and Novel Mechanism-of-Action (MOA) for
Optimizing Clinical Outcomes in Pediatric and Adult Patients with CAH LEARN MORE > 
Novel, Fractionated Dosing Formulations forOptimizing Titration of Carbidopa/Levodopa
A Practical Roadmap for Improving Patient Satisfaction, Motor Symptoms,
Clinical Outcomes, and ON/OFF Time in Persons with PD
LEARN MORE > 
The Role, Rationale, Evidence and Practical Application ofCombination Therapy with DTE in Selected Patients with Hypothyroidism
A Year 2021 Hypothyroidism Update for the Endocrinology, Primary Care, Internal Medicine, and Thyroid Specialist
LEARN MORE > 
Evidence, Guidelines, Mechanisms, and Trials Supporting Biologics-BasedTargeting of Type 2 Cytokine Signaling Proteins for Moderate-to-Severe AD in
Children, Adolescents and Adults A Year 2020 Clinical Practice Roadmap for the Pediatric and Adult Dermatology Specialist, Clinical Immunologist, Adolescent Physician, Allergist, Pediatrician and Related Specialists LEARN MORE >
Importance of Early Diagnosis, Testing, and Recognition of Unusual and Heterogeneous Symptoms and Hallmarks ofFabry Disease Across Multiple Clinical Specialties A Year 2020 Diagnostic, Assessment, and Fabry Disease Management Update for the GI, Neurological, Renal, CV, Dermatologic and Clinical Genetics Specialist LEARN MORE >
Therapeutic Advances, Novel Formulations and Patient Adherence for Optimizing Management ofMYCOBACTERIUM AVIUM COMPLEX (MAC) LUNG DISEASE
Focus on the Safety, Evidence and Rationale for Inhaled Antimicrobial Suspension
LEARN MORE > 
From Landmark CV Outcome Trials to the Front Lines of ASCVD Risk Reduction Focus on Trial-Based Evidence for PCSK9-Mediated LDL-C Lowering to Optimize Treatment and Prevention of ASCVD LEARN MORE > iQ&A interactive Medical Intelligence Zone welcomes your questions and your participation in the iQ&A community.
FEATURED MASTER CURRICULUM-BASED LEARNING AND CME (MCL-CME) SERIES
Featured Specialties
iQ&A (interactive Medical Intelligence) welcomes your questions and your participation in the iQ&A community.